Refine Search

  •  
  •  
Big Movers in the Stock Market

...17.70 Investors interpreted the good news for Tarceva as boosting prospects for this biotech's own cancer drug. Abatix Corp. down $1.55 at $7.23 A shareholder lawsuit was announced late Friday against the company, which sells industrial...

http://chronicle.augusta.com/stories/2004/04/27/fin_413588.shtml
Finance
1